Caption Management’s Evolent Health EVH Stock Holding History

Caption Management’s Portfolio EVH Stock Details EVH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-112,400	Closed	-$951K	–	1720
2025 Q3	$951K	Hold	112,400	–	–	0.01%	1123
2025 Q2	$1.27M	Sell	112,400 -100	-0.1%	-$918	0.01%	871
2025 Q1	$1.07M	Sell	112,500 -222,500	-66%	-$2.25M	0.01%	893
2024 Q4	$3.77M	Sell	335,000 -52,500	-14%	-$923K	0.04%	466
2024 Q3	$11M	Buy	387,500 +177,000	+84%	+$4.56M	0.17%	140
2024 Q2	$4.02M	Buy	210,500 +112,500	+115%	+$2.87M	0.06%	313
2024 Q1	$3.21M	Buy	+98,000	New	+$3.13M	0.05%	412
2022 Q4	–	Sell	-41,500	Closed	-$1.49M	–	1395
2022 Q3	$1.49M	Buy	+41,500	New	+$1.46M	0.02%	734
2021 Q4	–	Sell	-50,000	Closed	-$1.55M	–	1691
2021 Q3	$1.55M	Buy	+50,000	New	+$1.2M	0.02%	869
2020 Q3	–	Sell	-50,000	Closed	-$356K	–	1094
2020 Q2	$356K	Hold	50,000	–	–	0.01%	733
2020 Q1	$272K	Buy	+50,000	New	+$447K	0.02%	657

Other funds holding EVH

CCM

Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Rubicon Founders Nashville, Tennessee $138M AUM 61.96% 1-Year Est. Return

Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Caption Management's EVH Position: Q4 2025 in Review

Caption Management sold out of Evolent Health (EVH) in Q4 2025, closing a stake of 20,000 shares — an estimated $169K sold.

Caption Management first reported a position in EVH in Q2 2019 and held it in 12 quarters. The position peaked at $1.57M in Q2 2024. 215 funds tracked by Wall St. Rank hold EVH as of Q4 2025.

Caption Management reported no remaining Evolent Health position as of Q4 2025 after selling out during the quarter.
Caption Management sold 20,000 Evolent Health shares in Q4 2025, an estimated $169K.
Caption Management first reported a position in Evolent Health in Q2 2019 and held it in 12 quarters.
Caption Management's Evolent Health position peaked at $1.57M in Q2 2024.
215 funds tracked by Wall St. Rank held Evolent Health as of Q4 2025.

Based on Caption Management's 13F filing for Q4 2025, filed 17 Feb 2026.